AGP Executive Report
Last update: 5 hours agoExecutive Moves: Cosette Pharmaceuticals named David Bell Chief Commercial Officer for its 21-brand specialty portfolio, aiming to scale sales, marketing, market access, and integration of acquired assets. Clinical Leadership: Passkey Therapeutics tapped Mandeep Kaur, MD, as Chief Medical Officer to advance clinical development of combination therapies flagged by its computational genetics platform. Policy & Access: Puerto Rico’s Health Task Force shared a draft Medicaid strategy as about 1.5 million residents rely on the program, while HHS rescinded its new ACIP charter plan after an administrative timing misstep. Coverage & Costs: Louisiana lawmakers advanced a bill that could expand Medicaid coverage for FDA-approved weight-loss drugs (including GLP-1s) starting Jan. 1, 2027, pending funding. Patient Safety: Ochsner Rush Medical Center earned an “A” Hospital Safety Grade from the Leapfrog Group. Care Delivery Pressure: Gaza imaging capacity remains severely damaged, with most MRI and many CT/X-ray systems nonfunctional and spare parts hard to obtain. Public Health Focus: Viral Hepatitis Awareness Month spotlights testing gaps, especially for people with substance use disorder.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
Pseudo-journalism: Pink-slime
